Selected research
Market Structure
Global Crisaborole Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Crisaborole market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Crisaborole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Crisaborole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Crisaborole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Crisaborole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Crisaborole include Neuraxpharm, Tapi Teva, VIRUJ PHARMA, Synergy Pharmaceutical and Ausun Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Crisaborole market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Crisaborole and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Crisaborole sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Crisaborole market size, projected growth trends, production technologies, key applications, and end-use industries.
Crisaborole Segment by Company
Neuraxpharm
Tapi Teva
VIRUJ PHARMA
Synergy Pharmaceutical
Ausun Pharmaceutical
Crisaborole Segment by Type
Purity Above 98%
Purity Below 98%
Crisaborole Segment by Application
Allergic Dermatitis
Other
Crisaborole Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Crisaborole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Crisaborole and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Crisaborole.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Crisaborole market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Crisaborole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Crisaborole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Crisaborole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Purity Above 98%
- Purity Below 98%
Applications
- Allergic Dermatitis
- Other
Companies covered
- Neuraxpharm
- Tapi Teva
- VIRUJ PHARMA
- Synergy Pharmaceutical
- Ausun Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Crisaborole Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Crisaborole Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Crisaborole Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Crisaborole Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Crisaborole Market Dynamics
- 2.1 Crisaborole Industry Trends
- 2.2 Crisaborole Industry Drivers
- 2.3 Crisaborole Industry Opportunities and Challenges
- 2.4 Crisaborole Industry Restraints
3 Crisaborole Market by Manufacturers
- 3.1 Global Crisaborole Revenue by Manufacturers (2021-2026)
- 3.2 Global Crisaborole Sales by Manufacturers (2021-2026)
- 3.3 Global Crisaborole Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Crisaborole Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Crisaborole Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Crisaborole Manufacturers, Product Type & Application
- 3.7 Global Crisaborole Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Crisaborole Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Crisaborole Players Market Share by Revenue in 2025
- 3.8.3 2025 Crisaborole Tier 1, Tier 2, and Tier 3
4 Crisaborole Market by Type
- 4.1 Crisaborole Type Introduction
- 4.1.1 Purity Above 98%
- 4.1.2 Purity Below 98%
- 4.2 Global Crisaborole Sales by Type
- 4.2.1 Global Crisaborole Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Crisaborole Sales by Type (2021-2032)
- 4.2.3 Global Crisaborole Sales Market Share by Type (2021-2032)
- 4.3 Global Crisaborole Revenue by Type
- 4.3.1 Global Crisaborole Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Crisaborole Revenue by Type (2021-2032)
- 4.3.3 Global Crisaborole Revenue Market Share by Type (2021-2032)
5 Crisaborole Market by Application
- 5.1 Crisaborole Application Introduction
- 5.1.1 Allergic Dermatitis
- 5.1.2 Other
- 5.2 Global Crisaborole Sales by Application
- 5.2.1 Global Crisaborole Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Crisaborole Sales by Application (2021-2032)
- 5.2.3 Global Crisaborole Sales Market Share by Application (2021-2032)
- 5.3 Global Crisaborole Revenue by Application
- 5.3.1 Global Crisaborole Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Crisaborole Revenue by Application (2021-2032)
- 5.3.3 Global Crisaborole Revenue Market Share by Application (2021-2032)
6 Global Crisaborole Sales by Region
- 6.1 Global Crisaborole Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Crisaborole Sales by Region (2021-2032)
- 6.2.1 Global Crisaborole Sales by Region (2021-2026)
- 6.2.2 Global Crisaborole Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Crisaborole Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Crisaborole Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Crisaborole Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Crisaborole Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Crisaborole Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Crisaborole Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Crisaborole Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Crisaborole Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Crisaborole Revenue by Region
- 7.1 Global Crisaborole Revenue by Region
- 7.1.1 Global Crisaborole Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Crisaborole Revenue by Region (2021-2026)
- 7.1.3 Global Crisaborole Revenue by Region (2027-2032)
- 7.1.4 Global Crisaborole Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Crisaborole Revenue (2021-2032)
- 7.2.2 North America Crisaborole Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Crisaborole Revenue (2021-2032)
- 7.3.2 Europe Crisaborole Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Crisaborole Revenue (2021-2032)
- 7.4.2 Asia-Pacific Crisaborole Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Crisaborole Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Crisaborole Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Neuraxpharm
- 8.1.1 Neuraxpharm Company Information
- 8.1.2 Neuraxpharm Business Overview
- 8.1.3 Neuraxpharm Crisaborole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Neuraxpharm Crisaborole Product Portfolio
- 8.1.5 Neuraxpharm Recent Developments
- 8.2 Tapi Teva
- 8.2.1 Tapi Teva Company Information
- 8.2.2 Tapi Teva Business Overview
- 8.2.3 Tapi Teva Crisaborole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Tapi Teva Crisaborole Product Portfolio
- 8.2.5 Tapi Teva Recent Developments
- 8.3 VIRUJ PHARMA
- 8.3.1 VIRUJ PHARMA Company Information
- 8.3.2 VIRUJ PHARMA Business Overview
- 8.3.3 VIRUJ PHARMA Crisaborole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 VIRUJ PHARMA Crisaborole Product Portfolio
- 8.3.5 VIRUJ PHARMA Recent Developments
- 8.4 Synergy Pharmaceutical
- 8.4.1 Synergy Pharmaceutical Company Information
- 8.4.2 Synergy Pharmaceutical Business Overview
- 8.4.3 Synergy Pharmaceutical Crisaborole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Synergy Pharmaceutical Crisaborole Product Portfolio
- 8.4.5 Synergy Pharmaceutical Recent Developments
- 8.5 Ausun Pharmaceutical
- 8.5.1 Ausun Pharmaceutical Company Information
- 8.5.2 Ausun Pharmaceutical Business Overview
- 8.5.3 Ausun Pharmaceutical Crisaborole Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Ausun Pharmaceutical Crisaborole Product Portfolio
- 8.5.5 Ausun Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Crisaborole Value Chain Analysis
- 9.1.1 Crisaborole Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Crisaborole Production Mode & Process
- 9.2 Crisaborole Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Crisaborole Distributors
- 9.2.3 Crisaborole Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst